Journal article icon

Journal article

Variation in postoperative outcomes of patients with intracranial tumors: insights from a prospective international cohort study during the COVID-19 pandemic

Abstract:
BACKGROUND: This study assessed the international variation in surgical neuro-oncology practice and 30-day outcomes of patients who had surgery for an intracranial tumor during the COVID-19 pandemic./ METHODS: We prospectively included adults aged ≥18 years who underwent surgery for a malignant or benign intracranial tumor across 55 international hospitals from 26 countries. Each participating hospital recorded cases for 3 consecutive months from the start of the pandemic. We categorized patients’ location by World Bank income groups (high [HIC], upper-middle [UMIC], and low- and lower-middle [LLMIC]). Main outcomes were a change from routine management, SARS-CoV-2 infection, and 30-day mortality. We used a Bayesian multilevel logistic regression stratified by hospitals and adjusted for key confounders to estimate the association between income groups and mortality./ RESULTS: Among 1016 patients, the number of patients in each income group was 765 (75.3%) in HIC, 142 (14.0%) in UMIC, and 109 (10.7%) in LLMIC. The management of 200 (19.8%) patients changed from usual care, most commonly delayed surgery. Within 30 days after surgery, 14 (1.4%) patients had a COVID-19 diagnosis and 39 (3.8%) patients died. In the multivariable model, LLMIC was associated with increased mortality (odds ratio 2.83, 95% credible interval 1.37–5.74) compared to HIC./ CONCLUSIONS: The first wave of the pandemic had a significant impact on surgical decision-making. While the incidence of SARS-CoV-2 infection within 30 days after surgery was low, there was a disparity in mortality between countries and this warrants further examination to identify any modifiable factors
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1093/neuonc/noad019
Publication website:
https://discovery.ucl.ac.uk/10168250/1/noad019.pdf

Authors

More by this author
Role:
Author
ORCID:
0000-0002-0053-2184
More by this author
Role:
Author
ORCID:
0000-0002-6422-5853
More by this author
Role:
Author
ORCID:
0000-0002-3333-8636
More by this author
Role:
Author
ORCID:
0000-0001-6227-9930
More by this author
Role:
Author
ORCID:
0000-0001-8000-392X


More from this funder
Funder identifier:
10.13039/501100000272
Grant:
NIHR 16.136.79
More from this funder
Funder identifier:
10.13039/100009756
More from this funder
Funder identifier:
10.13039/100011703


Publisher:
Oxford University Press
Journal:
Neuro-Oncology More from this journal
Volume:
25
Issue:
7
Pages:
1299-1309
Publication date:
2023-04-13
DOI:
EISSN:
1523-5866
ISSN:
1522-8517


Language:
English
Keywords:
Pubs id:
1350125
Local pid:
pubs:1350125
Source identifiers:
W4365442816
Deposit date:
2026-05-08
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP